| ProductNum | picture | CAS No. | Name and description | Size | Price | Formula | Quick order |
|---|---|---|---|---|---|---|---|
| CYC001004 |
|
5625-46-7 |
Cycloserine Impurity 7 - - 95%+ |
0 | Inquiry | C6H10N2O2 | |
| CYC001003 |
|
302-84-1 |
Cycloserine Impurity 6 - - 95%+ |
0 | Inquiry | C3H7NO3 | |
| CYC001002 |
|
68-41-7 |
Cycloserine Impurity 4 - - 95%+ |
0 | Inquiry | C3H6N2O2 | |
| CYC001006 |
|
/ |
N/A - - 95%+ |
0 | Inquiry | C6 H12 N4 O4 | |
| CYC001005 |
|
/ |
N/A - - 95%+ |
0 | Inquiry | C3 H8 N2 O3 | |
| UPA001008 |
|
2715120-86-6 |
Upadacitinib Impurity 07 - - 95%+ |
0 | Inquiry | C20H21F6N7O2 | |
| UPA001007 |
|
/ |
Upadacitinib Impurity 06 - - 95%+ |
0 | Inquiry | C19 H23 F3 N6 O | |
| UPA001006 |
|
/ |
Upadacitinib Impurity 05 - - 95%+ |
0 | Inquiry | C17 H19 F3 N6 O | |
| UPA001005 |
|
/ |
Upadacitinib Impurity 04 - - 95%+ |
0 | Inquiry | C18 H21 F3 N6 O2 | |
| UPA001004 |
|
/ |
Upadacitinib Impurity 03 - - 95%+ |
0 | Inquiry | C18 H19 N7 O | |
| UPA001003 |
|
/ |
Upadacitinib Impurity 02 - - 95%+ |
0 | Inquiry | C19 H23 F3 N6 O | |
| UPA001002 |
|
1708997-43-6 |
Upadacitinib Impurity 01 - - 95%+ |
0 | Inquiry | C14H17N5 | |
| UPA001001 |
|
1310726-60-3 |
Upadacitinib - - 95%+ |
0 | Inquiry | C17H19F3N6O | |
| MET002005 |
|
19741-14-1 |
N/A - - 95%+ |
0 | Inquiry | C15H15N7O2 | |
| MET002004 |
|
2410-93-7 |
N/A - - 95%+ |
0 | Inquiry | C20H21N7O6 | |
| NET001001 |
|
40222-77-3 |
2-PyridineMethanol,5-hydroxy- - - 95%+ |
0 | Inquiry | C6H7NO2 | |
| BED001010 |
|
5409-58-5 |
(3-dimethylamino)-1'-propionaphthone-HCl - - 95%+ |
0 | Inquiry | C15H18ClNO | |
| AMI009001 |
|
2138811-33-1 |
Amlodipine Impurity D - - 95%+ |
0 | Inquiry | C24H27ClN2O9 | |
| BED001009 |
|
845533-86-0 |
Bedaquiline fumarate - - 95%+ |
0 | Inquiry | C36H35BrN2O6 | |
| BED001008 |
|
/ |
Bedaquiline Fumarate Impurity 8 - - 95%+ |
0 | Inquiry | C31H29BrN2O2 | |
Hotline
|
022-1561561656
|
|
After sale
|
022-1561561656
|